BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/7/2015 11:06:00 AM | Browse: 732 | Download: 855
Publication Name World Journal of Gastroenterology
Manuscript ID 12006
Country/Territory Israel
2014-06-20 09:11
Peer-Review Started
2014-06-20 16:19
To Make the First Decision
2014-07-21 14:07
Return for Revision
2014-07-28 16:18
2014-08-27 02:21
Second Decision
2014-09-30 10:03
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-09-30 10:29
Articles in Press
2014-09-30 10:56
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-12-24 21:05
Publish the Manuscript Online
2015-01-07 11:07
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Observational Study
Article Title Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis
Manuscript Source Unsolicited Manuscript
All Author List Moran Lavie, Tzipora Manovitz, Daphna Vilozni, Sarina Levy-Mendelovich, Ifat Sarouk, Ilana Weintraubv, David Shoseyov, Malena Cohen-Cymberknoh, Joseph Rivlin and Ori Efrati
Funding Agency and Grant Number
Corresponding Author Dr. Moran Lavie, Pediatric Pulmonary Unit and the National Center for Cystic Fibrosis, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Derech Sheba 2, Tel Hashomer 52621, Israel. moran.lavie@sheba.health.gov.il
Key Words Distal intestinal obstruction syndrome; Cystic fibrosis; Meconium ileus; Treatment; Recurrence
Core Tip Distal intestinal obstruction syndrome (DIOS) is a gastrointestinal complication of cystic fibrosis (CF). This study reviews the long-term follow-up of DIOS across two decades in Israeli CF patients. The DIOS patients were more prone to meconium ileus, Aspergillus spp. airway colonization and frequent hospitalizations then the DIOS-negative CF patients. DIOS recurrence was observed in 77% of patients. Conservative treatment was successful in 82% of the episodes, which makes it the treatment of choice for DIOS management. The survival rate was similar to the CF patients without DIOS.
Publish Date 2015-01-07 11:07
Citation Lavie M, Manovitz T, Vilozni D, Levy-Mendelovich S, Sarouk I, Weintraubv I, Shoseyov D, Cohen-Cymberknoh M, Rivlin J, Efrati O. Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis. World J Gastroenterol 2015; 21(1): 318-325
URL http://www.wjgnet.com/1007-9327/full/v21/i1/318.htm
DOI http://dx.doi.org/10.3748/wjg.v21.i1.318
Full Article (PDF) WJG-21-318.pdf
Full Article (Word) WJG-21-318.doc
Manuscript File 12006-Review.docx
Answering Reviewers 12006-Answering reviewers.pdf
Copyright License Agreement 12006-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 12006-Language certificate.pdf
Peer-review Report 12006-Peer review.pdf
Scientific Misconduct Check 12006-CorssCheck.jpg
Scientific Editor Work List 12006-Scientific editor work list.pdf